Onkologie, Hämatologie - Daten und Informationen

Literaturreferenzen zum Anhang der interdisziplinären S3-Leitlinie "Diagnostik, Therapie und Nachsorge des kolorektalen Karzinoms"

Interdisziplinäre S3-Leitlinie
Autor/en: Th. Junginger, W. Lorenz (Hrsg.)
Letzte Änderung: 07.04.2004
  • Alves A, Panis Y, Trancart D, Regimbeau JM, Pocard M,Valleur P.
    Factors associated with clinically significant anastomotic leakage after large bowel resection:multivariate analysis of 707 patients.
    World J Surg 2002;26:499-502. PM:11910487

  • Beart RW, Steele jr. GD, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP.
    Management and survival of patients with adenocarcinoma of the colon and rectum. A national survey of the Commission of Cancer.
    J Am Coll Surg 1995;181:225-236. PM:7670682

  • Bokey EL, Öjerskog B, Chapuis PH, Dent OF, Newland RC, Sinclair G.
    Local recurrence after curative excision of the rectum for cancer without adjuvant therapy:role of total anatomical dissection.
    Br J Surg 1999;86:1164-1170. PM:10504371

  • Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC.
    Surgical technique and survival in patients having a curative resection for colon cancer.
    Dis Colon Rectum 2003;46:860-66. PM:12847357

  • Bonadeo FA, Vaccato CA, Benati ML et al.
    Local recurrence after surgery without radiotherapy.
    Dis Colon Rectum 2001;44:374-379. PM:11289283

  • Cecil T, Moran BJ, Heald RJ.
    Total mesorectal excision:a quality controlled approach to rectal cancer surgery.
    In: Bleiberg H, Kemeny N, Rougier P, Wilke H (eds) Colorectal cancer. A clinical guide to therapy.
    Martin Dunitz, London 2002;pp 185-192.

  • Cecil T, Sexton R, Moran BJ, Heald RJ.
    Total mesorectal excision results in low local recurrence rates in (high risk) lymph node positive rectal cancer.
    Dis Colon Rectum 2004 (in press).

  • Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP.
    American Joint Committee on Cancer Prognostic Factors Consensus Conference. Colorectal Working Group.
    Cancer 2000a;88:1139-1157. PM:10738234

  • Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond MEH et al.
    Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.
    Arch Pathol Lab Med 2000b;124:979-994. PM:10888773

  • Copeland EM, Miller LD, Jones RS.
    Prognostic factors in carcinoma of the colon and rectum.
    Am J Surg 1968;116:875-884. PM:5723866

  • Dehni N, Schlegel RD, Cunningham C, Guiget M, Tiret E, Parc R.
    Influence of a defunctioning stoma on leakage rates after low colorectal anastomosis and colonic J pouch-anal anastomosis.
    Br J Surg 1998;85:1114-17. PM:9718009

  • Dehni N, McFadden N, McNamara DA et al.
    Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum.
    Dis Colon Rectum 2003;46:867-874. PM:12847358

  • Dixon AR, Maxwell WA, Thornton Holmes J.
    Carcinoma of the rectum:a 10-year experience.
    Br J Surg 1991;78:308-311. PM:2021845

  • Enker WE, Merchant N, Cohen AM, Lanouette NM, Swallow C, Guillem J, Paty P, Minsky B, Weyrauch K, Quan SH.
    Safety and efficacy of low anterior resection for rectal cancer:681 consecutive cases from a specially service.
    Ann Surg 1999;230:544,552.. PM:10522724

  • Enker WE, Thaler HT, Cranor ML et al.
    Total mesorectal excision in the operative treatment of carcinoma of the rectum.
    J Am Coll Surg 1995;181:335-346. PM:7551328

  • Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gatright B, Hermanek P et al.
    Clinicopathologic staging for colorectal cancer. An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).
    J Gastroenterol Hepatol 1991;6:325-344. PM:1912440

  • Göhl J, Hohenberger W.
    Laparoscopic TME:the surgeon`s or patient`s preference.
    In: Büchler W (ed).
    Rectal cancer treatment.
    Springer, Berlin-Heidelberg-New York, 2004 (in press).

  • Goldstein NS, Sanford W, Coffey M, Layfield LJ.
    Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.
    Am J Clin Pathol. 1996;106(2):209-16. PM:8712176

  • Hamilton SR, Aaltonen LA (eds).
    Pathology and genetics of tumours of the digestive system. WHO Classification of Tumours.
    IARC Press, Lyon, 2000.

  • Harrison JC, Dean PJ, El-Zeky F, Vander Zwaag R.
    From Dukes through Jass:Pathological prognostic indicators in rectal cancer.
    Hum Pathol 1994;25:498-505. PM:8200644

  • Havenga K, Enker WE, Norstein J et al.
    Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer:an international analysis of 1411 patients.
    Eur J Surg Oncol 1999;25:368-374. PM:10419706

  • Heald RJ, Husband EM, Ryall RD.
    The mesorectum in radical surgery - the clue to pelvic recurrence.
    Brit J Surg 1982;69:613-616. PM:6751457

  • Heald RJ, Smedh RK, Kald A et al.
    Abdominoperineal excision of the rectum. An endangered operation.
    Dis Colon Rectum 1997;40:747-751. PM:9221846

  • Hermanek P jr, Wiebelt H, Riedl St. et al.
    Langzeitergebnisse der chirurgischen Therapie des Coloncarcinoms.
    Ergebnisse der Studiengruppe Kolorektales Karzinom (SGKRK).
    Chirurg 1994;65:287-297. PM:8020349

  • Hermanek P, Guggenmoos-Holtmann I, Gall FP.
    Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.
    Dis Colon Rectum 1989;32:593-599. PM:2737060

  • Hermanek P, Sobin LH.
    Colorectal carcinoma.
    In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds).
    Prognostic factors in cancer.
    Springer, Berlin-Heidelberg-New York 1995.

  • Hermanek P, Mansmann U, Staimmer D, Riedl St, Hermanek P.
    The German experience. The surgeon as a prognostic factor in colon and rectal cancer surgery.
    Surg Oncol Clinics N Amer 2000;9:33-49. PM:10601523

  • Hermanek P, Hermanek P, Hohenberger W, Klimpfinger M, Köckerling F, Papadopoulos T.
    The pathologists assessment of mesorectal excision:implications for further treatment and quality management.
    Int J Colorect Dis 2003;18:335-341. PM:12774249

  • Hermanek P, Heald RJ.
    Preoperative radiotherapy for rectum carcinoma? Has the case really been made for short course preoperative radiotherapy if surgical standards for rectal carcinoma are optimal?
    Colorect Dis 2004;6:10-14. PM:14692945

  • Hobday TJ, Erlichmann C.
    Colorectal cancer.
    In:Gospodarowicz MK, Henson DE, Hutter RVP, O`Sullivan B, Solbin LH, Wittekind CH (eds).
    Prognostic factors in cancer, 2nd ed.
    John Willey & Sons, New York 2001.

  • Hohenberger W, .
    The effect of specialization or organisation of rectal cancer surgery.
    In:Soreide O, Norstein J (eds) Rectal cancer surgery. Optimisation - Standardisation - Documentation.
    Springer, Berlin Heidelberg New York 1997;pp. 353-363.

  • Holm T, Rutqvist LE, Johnston H, Cedermark B.
    Abdominoperineal resection and anterior resection in the treatment of rectal cancer:results in relation to adjuvant preoperative radiotherapy.
    Br J Surg 1995;82:1213-1216. PM:7551999

  • Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd LP.
    The grading of rectal cancer:historical perspectives and a multivariate analysis of 447 cases.
    Histopathology 1986;10:437-59. PM:3721406

  • Jessup JM, McGinnis LS, Steele jr GD, Menck HR, Winchester DP.
    The National Cancer Data Base report on colon cancer.
    Cancer 1996;78:918-926. PM:8756390

  • Junginger Th, Kneist W, Sultanov F, Heintz A.
    Qualitätsindikatoren der chrirugischen Therapie des Rektumkarzinoms.
    Chirurg 2003;74:444-451. PM:12748793

  • Kapiteijn E, Marijnen CA, Nagtegaal ID et al.
    Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.
    N Engl J Med 2001;345:638-46. PM:11547717.

  • Karanjia ND, Corder AP, Bearn P, Heald RJ.
    Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum.
    Br J Surg 1994;81:1224-26.. PM:7953369

  • Kasperk R, Willis S, Riesener KP, Schumpelick V.
    Evidence-based Chirurgie des Rektumkarzinoms.
    Zbl Chir 2001:126:295-301. PM:11370392

  • Kneist W, Heintz A, Wolf KH, Junginger Th.
    Totale Mesorektumexzision bei Karzinom des mittleren und unteren Rektumdrittels.
    Chirurg 2003;74:125-131. PM:12599030

  • Knudsen JB, Nilsson T, Sprechler M, Johansen A, Christensen N.
    Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum.
    Dis Colon Rectum 1983;26:613-17. PM:6872793

  • Ko CY, Chang JT, Chaudhry S, Kominski G.
    Are high-volume surgeons and hospitals the most important predictors of in-hospital outcome for colon cancer resection?
    Surgery. 2002;132(2):268-73. PM:12219022

  • Köckerling F.
    Qualitätssicherung Kolon/Rektum (Primärtumor). Endauswertung Jahrgang 2001.
    Veröffentlichung in Vorbereitung. Persönliche Mitteilung.

  • Kopp I, Koller M, Stinner B, Hainbach S, Rothmund M, Lorenz W.
    Chirurgische Therapie des Rektumkarzinoms der realen Versorgungssituation einer kreisbezogenen Qualitätssicherungsstudie.
    Chirurg 2001;72:1467-77. PM:11824034

  • Krook JE, Moertel GG, Gundersson LL et al.
    Effective surgical adjuvant therapy for high risk rectal carcinoma.
    N Engl J Med 1991;324:709-715. PM:1997835

  • Law WI, Chu KW, Ho JW, Chan CW.
    Risk factors for anastomotic leakage after low anterior resection with total mesorectal excision.
    Am J Surg 2000;179:92-96. PM:10773140

  • Link KH, Kornmann M, Staib L et al.
    Adjuvante Therapie beim Kolonkarzinom. Endresultate aus der FOGT 1-Studie. Abstract 2.
    Biebrich Interdisciplinary Conference, Oct 2-4/2003.

  • Lopez-Kostner F, Lavery IC, Hool GR et al.
    Total mesorectal excision is not necessary for cancers of the upper rectum.
    Surg 1998;124:612-618. PM:9780979

  • Marusch F, Koch A, Schmidt U, Pross M, Köckerling F et al.
    Stellenwert der Rektumexstirpation im Therapiekonzept des tief sitzenden Rektumkarzinoms.
    Chirurg 2003;74:341-352. PM:12719876

  • McCall JL, Cox MR, Wattchow DA.
    Analysis of local recurrence rates after surgery alone for rectal cancer.
    Int J Colorectal Dis. 1995;10:126-32. PM:7561427

  • Michelassi F, Mhoon DA.
    Functional results following rectal surgery:A review. In:Soreide O, Norstein J (eds.) Rectal cancer surgery. Optimisation - standardisation - documentation.
    Springer, Berlin Heidleberg New York 1997;337-352.

  • Mörschel M, Heintz A, Dienes H-P, Junginger Th.
    Lymphknotendissektion, Stadienverschiebung und perioperatives Risiko beim Rectumcarcinom.
    Chirurg 1996;67:915-920. PM:8991772

  • Murty M, Enker WE, Martz J.
    Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer.
    Seminars Surg Oncol 2000;19:321-328. PM:11241914

  • Newland RC, Dent OF, Chapuis PH, Bokey EL.
    Clinicopathologically diagnosed residual tumor after resection for colorectal cancer.
    Cancer 1993;72:1536-42. PM:8348488

  • Newland RC, Dent OF, Lyttle MNB, Chapuis PH, Bokey EL.
    Pathologic determinants of survival associated with lymph node metastases. A multivariate analysis of 579 patients.
    Cancer 1994;73:2076-82. PM:8156513

  • Petersen S, Freitag M, Hellmich G, Ludwig K.
    Anastomotic leakage:impact on local recurrence and survival in surgery of colorectal cancer.
    Int J Colorectal Dis 1998;13:160-163. PM:9810519

  • Pollard CW, Nivatvongs S, Rojanasakul A, Ilstrup DM.
    Carcinoma of the Rectum. Profiles of intraoperative and early postoperative complications.
    Dis Colon Rectum 1994;37:866-874. PM:8076485

  • Quirke P.
    Training and quality assurance for rectal cancer:20 years of data is enough.
    Lancet Oncol 2003;4:695-702. PM:14602250

  • Remmele W.
    Staging, typing and grading of colorectal cancer: a critical review of current classification systems.
    Progress Surg Pathol 1984;5:7-36.

  • Robles Campos R, Garcia Ayllon J, Parrila Paricio P, Cifuentes Tebar J, Lujan Mompean JA, Liron Ruiz R, Torralba Martinez JA, Molina Martinez J.
    Management of the perineal wound following abdominoperineal resection: prospective study of three methods.
    Br J Surg. 1992 Jan;79(1):29-31. PM:1531318

  • Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M.
    Risk factors for anastomotic leakage after resection of rectal cancer.
    Br J Surg 1998;85:355-58. PM:9529492

  • Scott KW, Grace RH.
    Detection of lymph node metastases in colorectal carcinoma before and after fat clearance.
    Br J Surg 1989:76:1165-1167. PM:2688803

  • Singh S, Morgan MBF, Broughton M , Caffarey S, Topham C, Marks CG.
    A 10-year prospective audit of outcome of surgical treatment for colorectal carcinoma.
    Br J Surg 1995;82:1486-1490. PM:8535799

  • Staib L, Link KH, Blatz A, Beger HG.
    Surgery of colorectal cancer: surgical morbidity and five-and ten-year results in 2400 patients - monoinstitutional experience.
    World J Surg 2002;26:59-66. PM:11898035

  • Swedish Rectal Caner Trial.
    Improved survival with preoperative radiotherapie in resectable rectal cancer.
    N Engl J Med 1997;336:980-987. PM:9091798

  • Taal BG, Van Tinteren H, Zoetmulder FAN on behalf of the NACCP group.
    Adjuvant 5FU plus levamisole in colonic or rectal cancer:improved survival in stage II and III.
    Br J Cancer 2001;85:1437-1443. PM:11720425

  • Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJR, Morson BC.
    Invasion of veins by carcinoma of the rectum:methods of detection, histological features and significances.
    Histopathology 1981;5:141-163. PM:7216178

  • Thomas GD, Dixon MF, Smeeton NC, Williams NS.
    Observer variation in the histological grading of rectal carcinoma.
    J Clin Pathol 1983;36:388-391. PM:6833507

  • Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi I, Kodaira S et al.
    Prognostic factors for patients with colon or rectal carcinoma treated with resection only.
    Cancer 1996;78:403-408. PM:8697383

  • UICC.
    Hermanek P, Henson DE, Hutter RVP, Sobin LH, eds.
    TNM Supplement 1993. A commentary on uniform use.
    Springer, Berlin-Heidelberg-New York p. 55, 1993.

  • UICC.
    Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin H, eds.
    Prognostic factors in cancer.
    Springer, Berlin-Heidelberg-New York 1995;pp. 64-79.

  • UICC.
    Sobin LH, Wittekind Ch, eds.
    TNM classification of malignant tumours 6th ed.
    Wiley & Sons, New York 2002.

  • UICC.
    Wittekind Ch, Greene FL, Henson DE, Hutter RVP, Sobin LH,. eds.
    TNM Supplement 3rd ed. A commentary on uniform use.
    John Wiley & Sons 2003;New York.

  • Vignali A, Fazio VW, Lavery IC, Milsom JW, Church JM, Hull TL, Strong SA, Oakley JR.
    Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients.
    J Am Coll Surg 1997;185:105-113. PM:9249076

  • Vobecky J, Leduc CP, Devroede G, Madarnas P.
    The reliability of routine pathologic diagnosis of colorectal adenocarcinoma.
    Cancer 1989;64:1261-1265. PM:2766222

  • Wille-Jörgensen P, Guenaga KF, Castro AA, Matos D.
    Clinical value of preoperative mechanical bowel cleansing in elective colorectal surgery:a systematic review.
    Dis Colon Rectum 2003;46:1013-20. PM:12907890

  • Wittekind Ch.
    Pathologiebefunde in der RCT-Studie 95 - Vorläufige kritische Wertung.
    Vortrag TME Kolloquium MERCURY-Studie, Berlin 01.12.2002.

  • Wong JH, Severino R, Hannebier MP, Tom P, Namiki TS.
    Number of nodes examined and staging accuracy in colorectal carcinoma.
    J Clin Oncol 1999;17:2896-2900. PM:10561368

  • Zaheer S, Pemberton JH, Farouk R et al.
    Surgical treatment of adenocarcinoma of the rectum.
    Ann Surg 1998;227:800-811. PM:9637543

  • Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P.
    Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Cancer 1997;79:2073-86. PM:9179053

Leitlinie "Kolorektales Karzi-
nom: Prävention, Diagnostik und Therapie 2004"; im Auf-
trag der Deutschen Gesell-
schaft für Verdauungs- und Stoffwechselkrankheiten,
1. Oktober 2004, Update 2007. [Mehr]
Das ONKODIN Projekt wird gefördert durch:
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch: